| To join our mailing list, enter your e-mail below:
|
|
Award Recipient Archives
To see all recipients of a specific award, select that award from the dropdown below. To see all recipients in a given year, select the year from the dropdown below.
Elizabeth Glaser Scientist Award
2006 - Margaret Feeney, M.D., M.Sc.Massacusetts General Hospital
Boston, Massachusetts
2006 Jewelers for Children Elizabeth Glaser Scientist Award
"The Immune Response to Acute Perinatal HIV Infection"
Dr. Feeney’s project will involve detailed longitudinal studies of the HIV-specific immune response and viral evolution during the early years following perinatal infection, and will build upon the existing collaboration with Dr. Celia Christie’s Perinatal AIDS Program in Kingston, Jamaica.
2006 - Alexandra Trkola, Ph.D.Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich
Zurich, Switzerland
“The Humoral Immune Response to HIV”
Dr. Trkola’s project will examine the humoral immune response to HIV in natural infection in order to define which antibody responses successful HIV vaccines should elicit.
2000 - Paul Krogstad, M.D.University of California Los Angeles School of Medicine
Los Angeles, California
Dr. Krogstad is studying the role of T-cell production and survival in children and adolescents with HIV/AIDS.
2000 - Douglas F. Nixon, M.B., B.S., D.Phil.The J. David Gladstone Institutes
San Francisco, California
Dr. Nixon is working to understand how antiviral white blood cells function in pediatric HIV infection, why they malfunction, and how these responses may be augmented or improved.
2000 - Julie Overbaugh, M.D.University of Washington
Seattle, Washington
Dr. Overbaugh is focused on research to further reduce HIV transmission from mother to infant through breastfeeding.
1999 - Robert W. Doms, M.D., Ph.D.University of Pennsylvania
Philadelphia, Pennsylvania
Dr. Doms investigated how HIV gets into cells to start an infection in an effort to block it.
1999 - Philip J.R. Goulder, M.R.C.P., D.Phil.University of Oxford
Oxford, England
Dr. Goulder's study examined the immune response of HIV-infected children in the U.S. and Africa to identify features which will be critical in the development of HIV vaccines.
1999 - Paul Johnson, M.D.Harvard Medical School
Boston, Massachusetts
Dr. Johnson's studies focused on developing a new approach to help boost immune response against HIV in HIV-infected children.
1998 - Mark B. Fienberg, M.D., Ph.D.Emory University School of Medicine
Atlanta, Georgia
Dr. Feinberg's research focused on developing a new HIV vaccine approach that would enable the safe and effective immunization of children and adolescents to protect them from HIV infection later in life.
1998 - Dana Gabuzda, M.D.Dana-Farber Cancer Institute
Boston, Massachusetts
Dr. Gabuzda studied the viral and host factors that lead to immunodeficiency and neurologic disease in pediatric AIDS.
1998 - Nathaniel (Ned) R. Landau, Ph.D.Salk Institute
La Jolla, California
Dr. Landau worked to understand the regulation of the gene that encodes the major HIV-1 coreceptor, CCR5, thereby understanding the process of mother-to-child HIV transmission and predicting which children are likely to progress rapidly to disease following infection.
1998 - Sarah Rowland-Jones, M.A., D.M., M.R.C.P.Institute of Molecular Medicine, University of Oxford
Oxford, England
Dr. Rowland-Jones' study focused on the immune response to HIV, particularly cytotoxic T-lymphocytes (CTL), or "killer cells," in children with extensive HIV exposure who have apparently resisted infection or who have survived an unusually long time with their HIV infection.
1998 - David Watkins, Ph.D.Wisconsin National Primate Center, University of Wisconsin
Madison, Wisconsin
Dr. Watkins worked to understand whether the cellular immune response can protect neonates and/or infants from infection or alter the course of the disease after HIV infection.
1997 - Bette Korber, Ph.D.Santa Fe Institute
Santa Fe, New Mexico
Dr. Korber maintained the Foundation's Ariel Project and Long-Term Survivor Study databases, to provide proper analysis as the experiments and auxiliary projects unfolded, and she developed new analytical tools in the process.
1997 - Andrew A. Lackner, D.V.M., Ph.D.New England National Primate Center, Harvard Medical School
Southborough, Massachusetts
Dr. Lackner's study sought to determine how HIV enters the brain and causes neurologic disease in pediatric patients.
1997 - Katherine Luzuriaga, M.D.Department of Pediatrics, University of Massachusetts Medical Center
Worcester, Massachusetts
Dr. Luzuriaga's work examined killer T-cell immune responses to HIV-1 infection or vaccination in infants.
1997 - Marta L.Marthas, Ph.D.California National Primate Research Center, University of California Davis
Davis, California
Dr. Marthas' work evaluated strategies to prevent mucosal HIV infection and AIDS in children using the SIV/neonatal-rhesus-macaque model of HIV infection.
1997 - John P. Moore, Ph.D.Joan and Sanford I. Weill Medical College of Cornell University
New York, New York
Dr. Moore studied how HIV-1 uses the second receptor CCR-5 to enter CD4+ T-cells, to help design drugs aimed at this process and to understand how the virus interacts with the developing immune systems of children.
1996 - Donald B. Kohn, M.D.Division of Research Immunology and Marrow Transplantation, Children's Hospital Los Angeles
Los Angeles, California
Dr. Kohn's research sought to develop effective gene therapy for pediatric AIDS in a series of clinical trials to examine whether or not T-cells can be made resistant to HIV. Gene therapy has been used to correct genetic disorders and now is being used to control HIV infection.
1996 - Richard Alan Koup, M.D.University of Texas, Southwestern Medical Center
Dallas, Texas
Dr. Koup's research sought to determine how natural resistance to HIV-1 infection in infants affects the likelihood of acquiring infection and the rate of progression to AIDS.
1996 - Joseph M. McCune, Ph.D., M.D.The J. Gladstone Institute of Virology and Immunology, San Francisco General Hospital
San Francisco, California
Dr. McCune sought to understand the effects of HIV-1 on the major organs of blood formation (bone marrow and thymus). His work was designed to enable scientists to better understand why HIV progresses more rapidly in infants than in adults.
1996 - Yves Rivière, D.V.M., Ph.D.Department of Virology and Cellular Immunology, L'Institut Pasteur
Paris, France
Dr. Rivière's work explored the role of HIV-specific cytotoxic activities in HIV-infected children. This study of immune cells may have determined why some patients die quickly while others live longer, healthier lives after becoming HIV-infected.
1996 - Jerome Zack, Ph.D.University of California Los Angeles School of Medicine, AIDS Institute
Los Angeles, California
Dr. Zack's study examined how HIV destroys specific cells in the developing immune system and ways to combat this destruction.
2006 - David Evans, Ph.D.Department of Microbiology and Molecular Genetics, New England National Primate Research Center
Southborough, Massachusetts
"Oral Transmission of Single-Cycle SIV in Neonates"
Dr. Evans' project will examine the earliest viral and cellular determinants of oral SIV infection in neonatal macaques, and is designed to reveal new insights important to understanding the mechanisms of breast milk transmission of HIV-1 from infected mothers to their infants.
2005 - Deborah Persaud, M.D.Johns Hopkins University School of Medicine
Baltimore, MD
Dr. Persaud will work to better understand the impact of early exposure to antiretroviral drugs in children who received treatment to prevent mother-to-child transmission (PMTCT) of HIV, but who became infected anyway.
At the 2005 Conference on Retroviruses and Opportunistic Infections (CROI), the Foundation bestowed Dr. Deborah Persaud with its highest honor, the Elizabeth Glaser Scientist Award (EGSA). Dr. Persaud's research will focus on drug resistance in children, an issue that is paramount to the future of the pediatric AIDS pandemic. With the aid of the Foundation’s funding, Dr. Persaud will work to better understand the impact of early exposure to antiretroviral drugs in children who received treatment to prevent mother-to-child transmission (PMTCT), but who became infected anyway. This increased comprehension could help doctors optimize treatment strategies and give children that develop drug-resistant HIV a better chance at improved long-term health and well-being. Peter Meyer, Elizabeth Glaser's brother, was on hand to present the award and emphasized that "[Elizabeth] would have been deeply grateful and excited about Dr. Persaud's pursuit of scientific advances and her tireless dedication to improving children's health."
2004 - Grace Aldrovandi, M.D.Children's Hospital Los Angeles
Los Angeles, CA
Dr. Aldrovandi's research seeks to understand how immune cells in breast milk work to suppress HIV.
2003 - Grace John-Stewart, M.D., M.P.H., Ph.D.University of Washington
Seattle, Washington
By defining immune responses in babies who resist HIV-1 infection in breast milk, Dr. John-Stewart is looking to identify ways to design and monitor a vaccine to prevent HIV-1 transmission in infants whose mothers choose to breastfeed because of concerns regarding stigma, cost, and infant risk due to formula feeding.
2002 - Jeffrey S.A. Stringer, M.D.University of Alabama Birmingham
University of Lusaka - Lusaka, Zambia
Dr. Stringer's study is intended to determine the optimal use of the anti-retroviral medication nevirapine to prevent the transmission of HIV from an infected mother to her infant.
2002 - Melissa A. Pope, Ph.D.Center for Biomedical Research, The Population Council
New York, New York
Dr. Pope's research is seeking to determine whether or not strategies for enhancing dendritic cell function can boost oral vaccine efficiency, a critical step in preventing infection with HIV and other pathogens in children.
2001 - Michael H. Malim, D.Phil.Guy's King's and St. Thomas' Medical School
London, England
Dr. Malim is seeking to understand how HIV bonds to the proteins Vif and Vpr in order to establish these proteins as potential targets for future anti-retroviral drugs.
2001 - Nina Bhardwaj, M.D., Ph.D.The Rockefeller University
New York, New York
Dr. Bhardwaj is studying the protective and therapeutic uses of dendritic cells for use in vaccines in children and adults infected with HIV-1.
2003 - Paul Bieniasz, Ph.D.Aaron Diamond AIDS Research Center/The Rockefeller University
New York, New York
Dr. Bieniasz has discovered that cells from rhesus macaques and other monkey species express an inhibitor that prevents them from becoming infected by HIV-1. He aims to determine activity of these inhibitors in humans and in monkeys and to define precisely which part of the virus is targeted.
2001 - Paul Clapham, Ph.D.University of Massachusetts Medical School
Boston, Massachusetts
Dr. Clapham is investigating how the use of different receptors influences the cellular tropisms of HIV.
2002 - Spyros A. Kalams, M.D.Vanderbilt University Medical Center
Nashville, Tennessee
Dr. Kalams is helping to identify the immune defects that lead to more rapid disease progression in children. This will aid in the design of immunotherapeutic strategies to correct these defects, as well as identify the types of immune responses that should be generated by HIV vaccines.
2001 - Sunil K. Ahuja, M.D.University of Texas
San Antonio, Texas
Dr. Ahuja is working to understand the genetic determinants that influence mother-to-child transmission of HIV and rate of disease progression in infected children.
2004 - Thomas Hope, Ph.D.University of Illinois Chicago
Chicago, Illinois
Dr. Hope is using state-of-the-art imaging methodologies to determine the mechanism of maternal-fetal transmission of HIV.
|
International Leadership Award
2007 - Assan Jaye, D.V.M., Ph.D.Medical Research Council (MRC) Laboratories
The Gambia, West Africa
“Establishment of a Pediatric HIV Clinical and Research Unit for the Study of Pathogenesis and Treatment of Pediatric HIV-1 and HIV-2 infection in The Gambia”
Dr. Jaye’s project will establish a pediatric HIV unit that will combine clinical and laboratory research in order to provide specialist care for HIV-positive children. In addition, it will be used as a setting to research pediatric HIV infection in West Africa.
2007 - Anneke C. Hesseling, M.D., M.Sc.Desmond Tutu TB Centre, Department of Pediatrics and Child Health and Faculty of Health Sciences
Stellenbosch University, Cape Town, South Africa
“Integrated HIV/TB Prevention Strategies to Reduce Morbidity in HIV-Infected Women and Their Infants in Highly Endemic Settings: Towards Integrated Comprehensive Maternal and Infant PMTCT Care”
Dr. Hesseling’s project aims to improve ante- and postnatal prevention of mother-to-child transmission (PMTCT) care and improve maternal and infant health outcomes by creating an integrated PMTCT program. The program will include routine antenatal maternal child health and tuberculosis (TB) testing and education, routine TB testing, and more.
2007 - Purnima Madhivanan, M.B.B.S., M.PH, Ph.D.Public Health Research Institute (PHRI)
Mysore, Karnataka, India
“Project Kisalaya (“young tender shoot” in Sanskrit): Integrating Traditional Birth Attendants in PMTCT Service Delivery in Mysore District, India”
Dr. Madhivanan’s project will set up a network of traditional birth attendants trained to identify and counsel pregnant women on prevention of mother-to-child transmission, and to refer antenatal cases to a mobile health care clinic.
2002 - Celia D.C. Christie, M.D., D.M. Paeds, M.P.H., F.A.A.P.University of the West Indies
Kingston, Jamaica
Pediatric and Perinatal HIV/AIDS Leadership Initiative
2004 - Clive Maurice Gray, Ph.D.National Institute of Communicable Diseases
Johannesburg, South Africa
Understanding Mechanisms of T-Cell Immunity in HIV-1 Infected and Exposed Newborns and Children
As part of his ILA award, Dr. Gray has created an online learning and networking program for South Africa. The program promotes knowledge and research in the field of HIV pediatric immunology among pediatricians, researchers, registrars, medical students, and others with an interest in pediatric immunology in South Africa.
www.immunopaedia.org.za
2002 - Dorothy A. Mbori-Ngacha, M.D.University of Nairobi
Nairobi, Kenya
Easibility and efficacy of "opt-out" antenatal HIV-1 testing to optimize HIV-1 test acceptance and preventive nevirapine therapy in HIV-1 seropositive women.
2002 - Francine Noel, M.D.Les Centres GHESKIO (Groupe Haitien d'Etude du Sarcome de Kaposi et des Infections Opportunistes)
Port-au-Prince, Haiti
A Model Program for HIV Pediatric Care in Haiti
2004 - Peter Kazembe, Mb.Ch.B., F.R.C.P.Malawi Medical Relief Trust
Lilongwe, Malawi
Malawi Pediatric AIDS Treatment and Training Implementation Project
2003 - Philippa Musoke, M.B., Ch.B., F.A.A.P.Makerere University
Kampala, Uganda
Anti-retroviral Therapy for treatment of HIV-infected children and training of health care workers in the use of these drugs in a developing country clinic setting
2003 - Pius Muffih Tih, M.P.H., Ph.D.Cameroon Baptist Convention Health Board
Northwest Province, Cameroon
Leadership development for implementation of a national program for PMTCT in Cameroon
2003 - Tammy Myers, M.D.University of Witwatersrand
Johannesburg, South Africa
Childhood HIV/AIDS Management Program
2004 - Thomas Gordon Egwang, M.Sc., Ph.D.Medical Biotechnology Laboratories
Kampala, Uganda
Standardized low-tech laboratory assays for sustainable health care of pediatric AIDS patients in resource-poor settings and an intensive re-training program for laboratory workers in the use of these assays in Uganda
|
Operations Research Grants
2007 - Benjamin Chi, M.D.University of Alabama at Birmingham/Centre for Infectious Disease Research in Zambia (CIDRZ)
Lusaka, Zambia
Non-Virologic Methods to Diagnose Antiretroviral Treatment Eligibility Among HIV-Exposed Infants Under 12 Months
2007 - Cathrien Alons, M.D.Elizabeth Glaser Pediatric AIDS Foundation
Maputo, Mozambique
Maternal HIV Seroconversion During Pregnancy and Breast-feeding Period: Incidence and Associated Risk Factors
2007 - Francis Martinson, M.D., Ph.D.University of North Carolina Chapel Hill
Lilongwe, Malawi
Improving Uptake of PMTCT and Integration of HIV-positive Mothers, Partners, and Children Into Long-term Care
2007 - John Odero Ong’ech, M.D.Elizabeth Glaser Pediatric AIDS Foundation
Nairobi, Kenya
Provision of Care and Early Infant Diagnosis for HIV-Exposed Infants: Evaluation of Maternal and Child (MCH) Model Versus the Comprehensive Care Clinic (CCC) Model
|
Pediatric HIV Vaccine Research Grants
2008 - Marylyn Addo, M.D., Ph.D.Massachusetts General Hospital
Charlestown, Massachusetts
Dr. Addo will attempt to determine if regulatory T cells in infants are responsible for the lack of control of HIV infection. The impact of these regulatory T cells on HIV-1 disease progression in infected infants is unknown. This information could be used to enhance the potency of immunotherapeutic interventions or HIV vaccines.
2008 - Grace Aldrovandi, M.D. Children's Hospital Los Angeles, USC
Los Angeles, California
Dr. Aldrovandi’s project involves the study of breast milk antibodies. From previous work in Zambia, she has samples of breast milk, plasma, and blood from HIV-positive mothers and their babies available to study. Dr. Aldrovandi will study the virus and breast milk antibodies from 700 women who did not transmit the virus to their babies, and compare them to those of 70 women who did transmit HIV to their babies during breast-feeding.
2008 - Dan Barouch, M.D., Ph.D.Beth Israel Deaconess Medical Center, Harvard University
Boston, Massachusetts
Dr. Barouch’s study will investigate the safety and efficacy of novel vaccine candidates in infant rhesus monkeys. This project will allow Dr. Barouch to direct his work in developing these new vaccine candidates from science solely focused on adult populations toward the potential to protect infants from breast-milk transmission of HIV.
2008 - Ed Janoff, M.D.University of Colorado Health Science Center
Denver, Colorado
Dr. Janoff’s study will investigate the impact of feeding from both the breast and the bottle versus breast-feeding alone on the susceptibility of infants to HIV infection. He will investigate the underlying mechanisms of how mixed feeding might predispose infants to greater risk of HIV infection.
2008 - Shan Lu, M.D., Ph.D.University of Massachusetts Medical School
Worcester, Massachusetts
Dr. Lu will study transmitted viruses with particular focus on the cell surface proteins that allow viral entry. He will study the virus proteins in mothers in comparison to those in their babies. The study will attempt to select those proteins, or parts of them, that elicit antibodies that can block infection.
|
Two-Year International Scholar Award
2005 - Herbert Kiyingi, Mb.Ch.B.Nsambya Hospital/Medbiotech Lab/EGPAF Collaboration
Kampala, Uganda
The Effect of Intermittent Presumptive Treatment With Sulfadoxine/Pyrimethamine to Control Malaria, on the Quality of Life and Survival in Ugandan Children Living With HIV/AIDS
2004 - Sam Ononge, M.Med., Mb.Ch.B.Makerere University
Kampala, Uganda
Expanded Access to PMTCT Services at Mulago Hospital
|
Two-Year Scholar Award
2005 - Melissa Farrow, Ph.D.College of the Holy Cross
Worcester, MA
Investigation of the expression of anti-HIV APOBEC3 family members
2005 - Vandana Kalia, Ph.D.Emory University School of Medicine
Atlanta, Georgia
Development of CD8 T Cell Immunological Memory
2005 - Surojit Sarkar, Ph.D.Emory University School of Medicine
Atlanta, Georgia
Immune Reconstitution and Reversal of T Cell Exhaustion During Chronic Infection
2004 - David Favre, D.V.M., Ph.D.The J. David Gladstone Institutes
San Francisco, California
HIV-1 Induced Dysfunction of Naïve CD8 T-cells
2003 - Geraldine Gillespie, Ph.D.Weatherall Institute of Molecular Medicine
Oxford, England
Characterization of Cross-Reactive CD8+ T-cell Immunity in HIV-1 Infection and in HIV-1 Vaccine Recipients
2002 - Lionel Berthoux, Ph.D.Columbia University
New York, New York
A Functional Screen for Cellular Targets of HIV-1 vif
2004 - Mansun Law, Ph.D.The Scripps Research Institute
La Jolla, California
Human Neutralizing Antibody Against Clade C HIV-1
2002 - Margaret Feeney, M.D.Massachusetts General Hospital
Charlestown, Massachussetts
Immune Control of HIV in Children
2003 - Renate Koenig, Ph.D.The Salk Institute
La Jolla, California
CCR5 Antagonists: Mechanism and Resistance
|
|
SEARCH
Foundation
Spotlight
Donate
Your contribution makes our work possible.
Sign Up for Our Newsletter
Keep up on the latest foundation news via e-mail.
Notes from the Field
First-person accounts of day-to-day Foundation field work.
|